I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Low-dose melittin is safe for intravitreal administration a..:
Moreira Castro, Brenda Fernanda
;
Nunes da Silva, Carolina
;
Barbosa Cordeiro, Lídia Pereira
...
Current Research in Pharmacology and Drug Discovery. 3 (2022) - p. 100107 , 2022
Link:
https://doi.org/10.1016/j.crphar.2022.100107
RT Journal T1
Low-dose melittin is safe for intravitreal administration and ameliorates inflammation in an experimental model of uveitis
UL https://suche.suub.uni-bremen.de/peid=cr-10.1016_j.crphar.2022.100107&Exemplar=1&LAN=DE A1 Moreira Castro, Brenda Fernanda A1 Nunes da Silva, Carolina A1 Barbosa Cordeiro, Lídia Pereira A1 Pereira de Freitas Cenachi, Sarah A1 Vasconcelos-Santos, Daniel Vitor A1 Machado, Renes Resende A1 Dias Heneine, Luiz Guilherme A1 Silva, Luciana Maria A1 Silva-Cunha, Armando A1 Fialho, Silvia Ligório PB Elsevier BV YR 2022 SN 2590-2571 JF Current Research in Pharmacology and Drug Discovery VO 3 SP 100107 LK http://dx.doi.org/https://doi.org/10.1016/j.crphar.2022.100107 DO https://doi.org/10.1016/j.crphar.2022.100107 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)